Signs (%)
Frequency
Vital Signs
Results Mean ± SD
All
Sporadic
Outbreak
P Value
General weakness
86
92
84
0.455
Systolic blood pressure (mmHg)
112 (18.4)
107.7 (18.2)
114.2 (18.5)
0.286
Dizziness
78
70
80
0.399
Diastolic blood pressure (mmHg)
71.5 (11.8)
73.3 (11.5)
70.8 (12.1)
0.536
Headache
51
20
62
0.026
Pulse rate (bpm)
88.3 (19)
89.9 (24.0)
87.8 (17.2)
0.748
Constipation
41
25
47
0.166
Respiration rate (bpm)
19 (5.3)
21.4 (6.9)
18.1 (4.4)
0.145
Symptoms (%)
Body temperature (c º)
37 (0.48)
37.1 (0.5)
37.0 (0.5)
0.371
Blurred vision
60
50
63
0.351
Paraclinical findings
Dry mouth
71
39
65
0.104
Nausea
57
58
56
0.588
Ptosis
91
0.733
Admission period (days)
5.3 (7.1)
5.1 (2.7)
5.4 (8.2)
0.907
Vomiting
33
22
0.339
Diplopia
81
67
87
0.146
Onset symptoms period (weeks)
8.3 (9.6)
3.8 (6.2)
9.1 (10.0)
0.312
Dysphagia
46
94
0.002
Elapsed period(hours)
40.2 (33.6)
17.7
47.2
Difficult speech
79
74
0.204
CPK (U/L)
146.9 (122.5)
101.7 (50.0)
159.9 (134.6)
0.314
Inability to keep the neck
30
0.586
Na (meq/L)
138.3 (4.5)
138.4 (4.8)
0.894
Mydriasis
14
36
7
0.320
K (meq/L)
4.0 (0.4)
4.2 (0.5)
4.1 (0.5)
0.509
Drooling
11
15
10
0.467
Creatinine (mg/L)
0.85 (0.2)
0.9 (0.3)
0.4 (0.2)
0.582
Hoarseness
0
--
Table 1: Frequency of signs and symptoms at the time of administration in all years study